44 related articles for article (PubMed ID: 19194828)
21. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
22. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP
Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549
[TBL] [Abstract][Full Text] [Related]
23. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.
Lee TL; Leung WK; Chan MW; Ng EK; Tong JH; Lo KW; Chung SC; Sung JJ; To KF
Clin Cancer Res; 2002 Jun; 8(6):1761-6. PubMed ID: 12060614
[TBL] [Abstract][Full Text] [Related]
24. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers.
Soria JC; Rodriguez M; Liu DD; Lee JJ; Hong WK; Mao L
Cancer Res; 2002 Jan; 62(2):351-5. PubMed ID: 11809677
[TBL] [Abstract][Full Text] [Related]
25. Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review.
Hayslip J; Montero A
Mol Cancer; 2006 Oct; 5():44. PubMed ID: 17026765
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation: its role in lung carcinogenesis and therapeutic implications.
Santos ES; Raez LE; DeCesare T; Singal R
Expert Rev Anticancer Ther; 2005 Aug; 5(4):667-79. PubMed ID: 16111467
[TBL] [Abstract][Full Text] [Related]
27. New applications and developments in the use of multiplex ligation-dependent probe amplification.
Kozlowski P; Jasinska AJ; Kwiatkowski DJ
Electrophoresis; 2008 Dec; 29(23):4627-36. PubMed ID: 19053154
[TBL] [Abstract][Full Text] [Related]
28. Adverse prognostic impact of CDKN2B hyper-methylation in acute promyelocytic leukemia.
Chim CS; Kwong YL
Leuk Lymphoma; 2006 May; 47(5):815-25. PubMed ID: 16753865
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation of GSTP1 as biomarker in diagnosis of prostate cancer.
Hopkins TG; Burns PA; Routledge MN
Urology; 2007 Jan; 69(1):11-6. PubMed ID: 17270599
[No Abstract] [Full Text] [Related]
30. Methylation and myelodysplastic syndromes: when and where?
Quesnel B
Leuk Res; 2006 Nov; 30(11):1327-9. PubMed ID: 16781771
[No Abstract] [Full Text] [Related]
31. Methylation profiles in breast cancer.
Buyru N; Altinisik J; Ozdemir F; Demokan S; Dalay N
Cancer Invest; 2009 Mar; 27(3):307-12. PubMed ID: 19194828
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
